The challenges we face
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help me?
Speak directly to a GM AHSN advisor with NHS expertise
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations
Connect you with relevant organisations
Innovation Nexus recognised for excellence in supporting life science businesses
Greater Manchester Academic Health Science Network (GM AHSN) has been honoured with Bionow’s 2016 Business Services Award for its Innovation Nexus service which provides healthcare SMEs with and advice and support to help them introduce their innovative solutions to the NHS.
The Innovation Nexus provides a single point of access for SMEs in the life science sector to a network of specialist support within Greater Manchester. It acts as a gateway between commercial innovators and key decision makers in the NHS and business support organisations, such as TRUSTECH and the Business Growth Hub; however the key part of the success of the Innovation Nexus is that its focus remains on the individual needs of a company.
How it works: https://www.youtube.com/watch?v=6V5lHxtSclk
The 15th annual Bionow Awards were held on 24th November 2016. They celebrate the best achievements in the life science sector in the North of England.
Developed to help GM AHSN deliver long-term health and wealth benefits to Greater Manchester, the Innovation Nexus supports SMEs that operate (or are interested in operating) in Greater Manchester, East Lancashire and East Cheshire. SMEs with solutions centred around GM AHSN’s priority areas of cardiovascular health, patient safety and digital health/informatics will fit the eligibility criteria perfectly, although those with innovative solutions outside of these areas are also encouraged to apply as the overarching aim remains to improve health outcomes for the local population.
Pictured from left to right: Paul Sinha - MC at the awards, Rachel Thompson - member of GM AHSN's Innovation Nexus Delivery Team, Dr Linda Magee - GM AHSN's Executive Director Industry & Wealth, John Willis - Business Engagement and Inward investment Manager at The Skills Growth Company.
At the time of the award, 265 companies had received support since the Innovation Nexus was launched just over two years ago in October 2014.
Two companies that have recently benefited from the Innovation Nexus are Humedics and U-Drain. Here are their stories.
Humedics is a Berlin-based company who specialise in instant and exact liver function measurement to help monitor and improve outcomes for patients undergoing liver surgery or receiving oncological therapy. The company are seeking to expand their global operation and identified Manchester as a key location to access the NHS. Through the Innovation Nexus, Humedics were introduced to The MedTECH Centre, where they established a local base and the company is currently engaging with a number of Greater Manchester NHS Trusts with a view to conducting a clinical study of their technology.
U-Drain is an SME based Greater Manchester. Their unique home drainage system offers patients on automated peritoneal dialysis a more friendly and efficient method of fluid disposal. Innovation Nexus has helped the company to secure funding to carry out an evaluation of their technology with a Greater Manchester NHS Trust.
Dr Linda Magee, Executive Director of Industry and Wealth at GM AHSN, was at the award ceremony to collect the award. Linda, who is responsible for ensuring the success of the Innovation Nexus, said:
“There are lots of innovations born out of SMEs that have the capacity to impact profoundly on the health and wellbeing of patients. Unfortunately access to, and navigating the life science market is complex and challenging. This is where the Innovation Nexus can help.
Although only two-years old, we have already had some great successes and we are elated to have won this award”.